Will Stone

Will Stone is a KUNR alumnus, having served as a passionate, talented reporter for KUNR for nearly two years before moving in early 2015 to the major Phoenix market at public radio station KJZZ.

An East Coast transplant, he's worked at NPR stations in Philadelphia, New York and Connecticut. He's also interned at the NPR West Headquarters in Los Angeles where he learned from some of the network's best correspondents. Before joining the public radio airwaves, he studied English at a small liberal arts college and covered arts and culture for an alternative newsweekly in Philadelphia.

He's particularly drawn to education, government and environmental reporting, as listeners became aware, he jumped on any story that got him out into the field with a mic in hand.

He enjoyed the Reno outdoors, food and cultural scene, given his liking for  hiking, fish tacos and great American poetry. While KUNR listeners miss his reporting, we're always glad to help prepare, encourage and support successful public radio professionals wherever they go.

See what Will is up to at KJZZ.

Federal health officials are urging Americans to shore up their immunity ahead of the winter holidays by getting a COVID-19 booster shot. But not everyone is working with the same defenses when it comes to keeping the virus at bay.

More than 47 million people in the U.S have already caught the coronavirus, at least according to officially recorded numbers. In reality, it's probably many millions more.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

The FDA this morning authorized COVID booster shots for all vaccinated Americans 18 and older. And the CDC, which has the final say, expects its advisers to weigh in on boosters this afternoon. Earlier today, I talked to NPR's Will Stone.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

It's a worrying sign for the U.S. ahead of the holiday travel season: coronavirus infections are rising in more than half of all states. Experts warn this could be the start of an extended winter surge.

The rise is a turnaround after cases had steadily declined from mid September to late October. The country is now averaging more than 83,000 cases a day — about a 14% increase compared to a week ago, and 12% more than two weeks ago.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AUDIE CORNISH, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

The U.S. has settled into an uneasy, drawn-out exit from the delta surge that took hold over the summer.

For many weeks, declining cases and hospitalizations have offered hope ahead of the holiday season, when Americans travel and spend more time indoors, but progress has stalled recently, with cases rising or plateauing in more than 20 states.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

The number of Americans hospitalized for COVID is now less than half of what it was in early September. That is good news, but it masks some trouble spots, especially in the northern half of the country. NPR's Will Stone reports.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

ASMA KHALID, HOST:

Updated November 2, 2021 at 7:34 AM ET

Millions of Americans can now opt for an extra shot of protection against COVID-19, regardless of which vaccine they initially received.

The criteria for a booster shot can include your age, job, where you live and your underlying health. In most cases, you have to wait until six months after your first two shots. What's more, a booster shot doesn't have to match the first vaccine you had.

When Colin Powell died this week from complications related to COVID-19, it was a shock to many Americans.

Though scientists and federal health officials are adamant that the vaccines work well to protect against hospitalization and death, it's unnerving to hear of fully vaccinated people like Powell, or perhaps your own friends and neighbors, falling severely ill with COVID-19.

So how well do the vaccines work? How serious is the risk of a serious breakthrough infection, one that could land you in the hospital?

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

With a second pandemic winter approaching, there are promising signs that the worst of the delta surge has run its course, but in America's hospitals — already short-staffed and backlogged from the summer torrent of COVID-19 — the relief may be only short-lived.

Many are staring down a tough stretch of colder months with the threat of a potentially bad influenza season, an influx of patients trying to catch up on delayed care and a depleted workforce that has had little time — if any — to regroup from this latest wave of coronavirus infections.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

The test results that hot day in early August shouldn't have surprised me — all the symptoms were there. A few days earlier, fatigue had enveloped me like a weighted blanket. I chalked it up to my weekend of travel. Next, a headache clamped down on the back of my skull. Then my eyeballs started to ache. And soon enough, everything tasted like nothing.

The U.S. health care system is again buckling under the weight of a COVID-19 surge that has filled more than 100,000 hospital beds nationwide and forced some states to consider enacting "crisis standards of care" — a last resort plan for rationing medical care during a catastrophic event.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AUDIE CORNISH, HOST:

Currently, more than 100,000 Americans are in the hospital with COVID-19, and that's not so far below the all-time hospitalization peak in January. NPR's Will Stone reports that has some states talking about rationing care.

Booster shots against the coronavirus have already started rolling out in the U.S. for some people and millions more could be due for them soon. But as breakthrough infections become more common, many people are wondering in the meantime: Does my immune system have enough firepower to protect me right now?

With the U.S. in the grips of a frightening surge of coronavirus cases, many parents are understandably eager to know when the COVID-19 vaccine will finally be available for children under 12.

This age group accounts for about 50 million Americans and currently none of them qualify for a shot. But scientists are racing to figure out how one of the COVID-19 vaccines currently available for adults could be given to this age group.

People with compromised immune systems who already got two doses of the Pfizer or Moderna vaccines can now get a third shot to boost their protection from COVID-19.

This week's decision by federal health agencies is welcome news to many patients and their doctors who have been calling for this for months.

The Food and Drug Administration is authorizing an additional dose of a COVID-19 vaccine for certain people with weakened immune systems caused either by disease, medical treatments or organ transplants.

The move comes after studies have shown these people may not have sufficient immunity to head off the more serious complications of COVID-19 after the standard vaccine regimen.

The vast majority of COVID-19 vaccines have gone straight from drug companies to affluent countries such as the United States. Worldwide only about 1% have made it to low-income countries.

And here's what's happening all across the United States: Millions of vaccine doses at risk of spoiling are sitting on freezer shelves, with no easy way to get them to countries desperately waiting for shots.

Updated August 3, 2021 at 5:00 PM ET

The U.S. has delivered 110 million COVID-19 vaccine doses to 65 countries, from Afghanistan to Zambia, President Biden announced Tuesday at the White House.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

In Peru, Dr. Ramiro Lazo Camposano, a pediatrician, was going door-to-door seeing his patients in the capital city of Lima at a time when most health care workers in the U.S. had already celebrated getting their second shots of the COVID vaccine. But he was not vaccinated. Doses were in short supply across Peru.

Eventually, Lazo Camposano, 74, caught the virus and passed it onto his son.

"Both went to the ICU unit, and they didn't make it," says his daughter Dr. Marcela Lazo Escalante, a physician and medical researcher in Lima. Father and son died in February.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

It's still a mystery. How did the pandemic begin?

There is the leading hypothesis among scientists: The virus hopped from an animal — possibly a bat — to a human, or to some other animal, which later spread the disease to humans.

And then there is the lab leak hypothesis: The virus somehow escaped from the Wuhan Institute of Virology.

Pages